CryoCell International Inc

Healthcare · Medical Care Facilities

4.00$ +1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

CryoCell International Inc (CCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 61 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CCEL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	18	20	20	21	21	24	22	22	43	42	43	41	42	43	45	45	44	46	105	58	59	61	55	55	67	65	66	69	70	61	62	63	63	65	64	64	63	62	61	61
Current Assets	10	9.0	9.3	11	11	13	13	13	30	30	30	15	16	15	17	17	17	19	19	15	15	16	9.7	10	11	9.6	11	10	9.9	9.5	9.5	10	11	13	13	13	12	12	11	11
Cash	2.0	3.5	3.5	4.7	4.7	6.3	7.0	6.5	7.0	6.0	7.1	6.5	7.3	6.5	8.4	8.4	8.1	10	11	7.9	7.7	8.3	2.1	2.8	2.9	1.7	1.4	1.1	0.6	0.4	0.2	0.5	0.2	0.6	0.2	0.1	0.3	0.3	0.2	0.5
Cash & Short-Term Investments	2.7	4.1	4.0	5.2	5.2	6.7	7.6	7.1	8.0	6.9	7.9	7.3	8.2	7.4	9.4	9.3	8.2	10	11	8.0	7.8	8.3	2.6	2.9	3.0	1.7	2.2	1.7	1.2	1.0	1.0	1.5	2.1	3.5	3.5	4.4	3.2	3.3	2.9	3.2
Receivables	4.4	4.1	4.4	4.6	4.9	5.1	4.9	4.8	5.5	5.9	5.7	5.8	5.9	6.1	5.8	6.0	6.5	6.3	5.6	5.2	5.4	5.3	5.2	5.2	5.3	6.0	6.5	6.7	6.4	6.6	6.7	6.8	6.9	7.3	7.2	6.9	6.8	6.8	6.8	6.9
Inventory	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.4	16	16	16	1.0	1.0	1.1	1.1	1.1	1.2	0.9	0.9	0.9	0.8	0.9	0.9	0.9	0.9	0.9	0.9	0.9	1.1	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.4	0.4	0.3
Property, Plant & Equipment	1.0	1.0	0.9	0.9	0.9	0.9	1.1	1.0	1.5	1.5	1.5	1.7	1.8	1.8	2.3	2.2	1.7	1.6	1.6	1.6	4.0	4.1	4.6	4.8	16	14	14	17	20	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.1	–	–	–	–	–	–	0.0	2.0	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9
Intangible Assets	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	1.4	1.3	1.3	1.3	1.3	1.2	1.2	1.2	1.5	1.5	60	17	16	16	16	16	15	15	15	15	14	1.0	1.0	1.0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.8
Total Liabilities	35	35	35	35	35	36	36	36	52	51	52	49	49	50	51	50	48	49	107	54	55	56	51	51	69	66	67	70	70	72	72	73	72	78	79	80	78	80	79	78
Current Liabilities	12	13	13	13	13	14	13	13	15	15	15	14	14	15	16	15	14	16	30	20	20	21	16	16	24	19	19	20	19	21	19	19	17	22	22	22	18	20	18	16
Short-Term Debt	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	3.1	3.1	3.1	3.1	3.1	3.1	0.5	3.4	3.4	3.1	3.3	3.4	3.0	2.2	1.4	0.7	0.5	2.7	2.2	2.2	3.1	1.6	2.4	4.7	2.8	4.1	5.2	7.3	3.6	2.9	2.0	0.6
Accounts Payable	1.6	1.5	1.5	1.2	1.4	1.9	1.2	1.1	1.1	1.3	1.0	1.0	1.0	1.4	1.4	1.0	0.9	3.9	0.9	1.2	1.0	1.5	1.8	1.7	1.8	1.6	2.4	4.1	2.8	3.2	3.0	1.8	2.0	1.9	2.7	2.2	2.6	2.9	3.3	2.8
Long-Term Debt	8.7	7.8	7.4	6.9	5.8	5.3	4.8	4.3	12	9.8	9.1	8.4	6.6	5.9	5.1	4.4	3.6	2.8	1.1	0.3	–	–	–	–	8.6	8.6	8.5	8.5	8.5	8.4	8.4	8.4	8.3	8.3	8.3	8.2	–	8.2	8.1	8.1
Shareholders' Equity	-17	-15	-15	-14	-13	-13	-14	-14	-9.8	-8.9	-8.2	-8.1	-7.0	-7.0	-6.0	-5.0	-4.0	-2.7	-1.7	4.0	4.8	4.2	4.3	4.4	-2.4	-1.5	-0.7	-0.9	0.0	-11	-10	-11	-9.6	-13	-15	-16	-15	-19	-18	-18
Retained Earnings	-28	-27	-26	-26	-25	-24	-27	-26	-26	-25	-24	-24	-23	-22	-22	-21	-20	-19	-18	-17	-16	-17	-16	-15	-22	-22	-21	-21	-20	-31	-31	-30	-29	-33	-35	-35	-35	-38	-38	-38
Shares Outstanding	7.6	6.9	7.4	7.7	7.8	7.1	7.1	7.9	8.4	7.8	8.4	8.4	8.4	7.5	8.1	8.1	8.2	7.5	8.2	8.3	8.7	8.4	8.7	8.6	8.4	8.5	8.4	8.3	8.3	8.3	8.3	8.2	8.2	8.2	8.2	8.1	8.1	8.1	8.1	8.1

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings